Research Article
Volume 4 Issue 5 - 2020
Cost-Effectiveness of Comprehensive Screening of General Population for Hypertension: Can it Save Money and Life? Systematic Review of Pharmacoeconomic Studies
Majid Davari, Mende Mensa Sorato* and Shekoufeh Nikfar
Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Iran
*Corresponding Author: Mende Mensa Sorato, Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Iran.
Received: April 15, 2020; Published: April 28, 2020




Abstract

Background: Hypertension is one of the major modifiable risk factors contributing for development of ischemic heart disease, diabetes, kidney disease, cerebrovascular disease and peripheral arterial disease. Early screening, detection and treatment of hypertension is effective for control of the disease progression. However, there is no robust evidence on whether screening general population for hypertension is cost-effective or not. Therefore, this systematic review was conducted to generate evidence on cost effectiveness of population-based screening for hypertension.

Methods: PubMed/Medline, Scopus, Web of sciences and Google Scholar were searched from January 2000 to 11 December 2019. Two investigators independently selected and reviewed pharmacoeconomic studies.

Results: Eleven studies were included in this review. All studies showed that screening people who are 40 years or older with high risk for cardiovascular disease is cost-effective. Screening of general adult population for hypertension is not-cost effective. Screening in developing countries is challenged by limited access to health care, in adequate health task force, poor financial protection and low health literacy of the population. Integrating multiple interventions, task shifting and using local opportunities for addressing the target population are important possibilities to improve opportunistic screening.

Conclusion: There is no adequate evidence to recommend screening of asymptomatic adults with no risk factor hypertension. Screening high risk populations aged 40 years and older at least annually is cost-effective in reducing hypertension and associated cardiovascular disease morbidity and mortality in developed and developing countries. Therefore, more strong economic evaluations from different perspectives are required to recommend general screening for hypertension.

Keywords: Screening Asymptomatic Populations; Hypertension; Cardiovascular Disease; Developing Countries

References

  1. Bhatt H., et al. “BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?” Current Cardiology Reports10 (2016): 98.
  2. Brand M., et al. “Chronic diseases are not being managed effectively in either high-risk or low-risk populations in South Africa”. South African Medical Journal 12 (2013): 938-941.
  3. Mohan V and Seedat Y. “The Rising Burden of Diabetes and Hypertension in Southeast Asian and African Regions: Need for Effective Strategies for Prevention and Control in Primary Health Care Settings”. International Journal of Hypertension (2013).
  4. Whelton PK CR., et al. “ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines”. Hypertension 71 (2017): e13-e115.
  5. Geldsetzer P., et al. “The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults”. The Lancet10199 (2019): 652-662.
  6. Proia KK., et al. “Team-Based Care and Improved Blood Pressure Control: A Community Guide Systematic Review”. American Journal of Preventive Medicine1 (2014): 86-99.
  7. Shlay JC., et al. “Peer Reviewed: Reducing Cardiovascular Disease Risk Using Patient Navigators, Denver, Colorado, 2007-2009”. Preventing Chronic Disease6 (2011).
  8. Durao S., et al. “Evidence insufficient to confirm the value of population screening for diabetes and hypertension in low- and-middle-income settings”. South African Medical Journal 2 (2015): 98-102.
  9. Margaret A Piper., et al. “Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force: Evidence Synthesis”. In: AHRQ Publication No. 13-05194-EF-1. Rockville MAfHRaQ, editor. US: AHRQ Publication (2014): 1-305.
  10. Davidson PM and Reid C. “Population screening an important step in identifying and increasing awareness of cardiovascular disease in developing countries”. Heart Lung and Circulation 2 (2012): 61-62.
  11. Correia JC., et al. “Interventions targeting hypertension and diabetes mellitus at community and primary healthcare level in low- and middle-income countries: a scoping review”. BMC Public Health 1 (2019): 1542.
  12. Adler AJ., et al. “Reducing cardiovascular mortality through prevention and management of raised blood pressure”. Glob Heart2 (2015): 111-122.
  13. Moher D., et al. “Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement”. Systematic Reviews 4 (2015): 1.
  14. Rascati K. “Essentials of pharmacoeconomics”. Lippincott Williams and Wilkins (2013).
  15. Evers S., et al. “Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria”. International Journal of Technology Assessment in Health Care2 (2005): 240-245.
  16. Jefferson T., et al. “Quality of systematic reviews of economic evaluations in health care”. The Journal of the American Medical Association 21 (2002): 2809-2812.
  17. Downes MJ., et al. “Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)”. BMJ Open 12 (2016): e011458.
  18. Ferket BS., et al. “Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease”. Heart (British Cardiac Society) 7 (2017): 483-491.
  19. Dukpa W., et al. “Is diabetes and hypertension screening worthwhile in resource-limited settings? An economic evaluation based on a pilot of a Package of Essential Non-communicable disease interventions in Bhutan”. Health Policy and Planning8 (2015):1032-1043.
  20. Kypridemos C., et al. “Future cost-effectiveness and equity of the NHS Health Check cardiovascular disease prevention programme: Microsimulation modelling using data from Liverpool, UK”. PLoS Medicine5 (2018): e1002573.
  21. Rattanavipapong W., et al. “One Step Back, Two Steps Forward: An Economic Evaluation of the PEN Program in Indonesia”. Health Systems and Reform1 (2016): 84-98.
  22. Howard K., et al. “Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis”. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research2 (2010): 196-208.
  23. Nguyen TPL., et al. “Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam”. PloS One 5 (2016).
  24. Van Buuren S., et al. “Toward targeted hypertension screening guidelines”. Medical decision making : an international journal of the Society for Medical Decision Making2 (2006):145-153.
  25. Rosendaal NTA., et al. “Costs and cost-effectiveness of hypertension screening and treatment in adults with hypertension in rural Nigeria in the context of a health insurance program”. PloS One6 (2016).
  26. Van de Vijver S., et al. “Introducing a model of cardiovascular prevention in Nairobi's slums by integrating a public health and private-sector approach: the SCALE-UP study”. Global Health Action 6 (2013): 22510.
  27. Dehmer SP., et al. “Health Benefits and Cost-Effectiveness of Asymptomatic Screening for Hypertension and High Cholesterol and Aspirin Counseling for Primary Prevention”. Annals of Family Medicine1 (2017): 23-36.
  28. Wang YC., et al. “Effectiveness and Cost-Effectiveness of Blood Pressure Screening in Adolescents in the United States”. The Journal of Pediatrics2 (2011): 257-64.e7.
  29. Rosendaal NTA HM., et al. “Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program”. PLoS One6 (2016): e0157925.
  30. Florin D and Dixon J. “Public involvement in health care”. British Medical Journal 7432 (2004): 159-161.
  31. Jeet G., et al. “Community health workers for non-communicable diseases prevention and control in developing countries: Evidence and implications”. PloS One 7 (2017): e180640.
  32. Ciapponi A., et al. “Delivery arrangements for health systems in low‐income countries: an overview of systematic reviews”. Cochrane Database of Systematic Reviews 9 (2017): CD011083.
  33. McBrien KA., et al. “Patient navigators for people with chronic disease: a systematic review”. PloS One 2 (2018): e0191980.
  34. “Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low-Resource Settings (2013).
  35. Krogsbøll LT., et al. “General health checks in adults for reducing morbidity and mortality from disease”. Cochrane Database of Systematic Reviews 1 (2019).
  36. Mende Mensa Sorato., et al. “Health Care System Response to Cardiovascular Diseases, Trends from 2010-2018: Can Ethiopia Achieve 2025 Global Voluntary Targets for Non-Communicable Diseases from Cardiovascular Diseases Perspective?” Explanatory Review of Available Literatures. Research and Reviews: Journal of Medical and Health Sciences1 (2019): 1-13.
  37. Gaziano TA., et al. “Hypertension education and adherence in South Africa: a cost-effectiveness analysis of community health workers”. BMC Public Health 14 (2014): 240.
Citation: Mende Mensa Sorato., et al. “Cost-Effectiveness of Comprehensive Screening of General Population for Hypertension: Can it Save Money and Life? Systematic Review of Pharmacoeconomic Studies”. EC Diabetes and Metabolic Research 4.5 (2020): 13-25.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.